TABLE 1.

Dengue seroprevalence by age, reported in some studies from India.

Padbidri et al. (2002) (n = 717)		(Garg et al., 2011) (n = 2,558)		(Rodríguez-Barraquer et al., 2015) (n = 800)		(Murhekar et al., 2019) (n = 12,300)		(Shah et al., 2017) (n = 700)
Age (years)	Seroprevalence (%)	Age (years)	Seroprevalence (%)	Age (years)	Seroprevalence (%)	Age (years)	Seroprevalence (%)	Age (years)	Seroprevalence (%)
0–9	47.60%	5	40.70%	9-May	77%	8-May	33.00%	0–10	13.70%
19-Oct	24.00%	6	50.90%	14-Oct	90.30%	17-Sep	34.70%	20-Nov	30.10%
20–29	26.80%	7	58.60%	15–19	91.70%	18–45	32.30%	21–30	45.10%
30–39	25.00%	8	67.40%	20–29	96.30%	—	—	31–40	59.70%
≥40	23.30%	9	70.80%	30–40	98.80%	—	—	≥40	64.10%
—	—	10	73.40%	—	—	—	—	—	—
Total	25.4 (95% CI = 22.3–28.7)	—	59.6 (95% CI = 57.7–61.5)	—	93 (95% CI = 91.1–94.6)	—	-—	—	42.8 (CI = 40.9–44.7)